Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 7, Pages 1542-1560
Publisher
Springer Nature
Online
2018-05-02
DOI
10.1038/s41375-018-0040-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies
- (2017) Andrzej J. Jakubowiak et al. Hematology
- Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
- (2017) J Flores-Montero et al. LEUKEMIA
- Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma
- (2016) Rimda Wanchoo et al. Clinical Journal of the American Society of Nephrology
- Management of Carfilzomib-Associated Cardiac Adverse Events
- (2016) Joseph Mikhael Clinical Lymphoma Myeloma & Leukemia
- Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide
- (2016) Nianhang Chen et al. CLINICAL PHARMACOKINETICS
- Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials
- (2016) David S. Siegel et al. LEUKEMIA & LYMPHOMA
- Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial
- (2016) J R Jones et al. Blood Cancer Journal
- Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
- (2016) A Rosenthal et al. Blood Cancer Journal
- Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
- (2015) Michael Sandherr et al. ANNALS OF HEMATOLOGY
- Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy
- (2015) Benjamin W. Teh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
- (2015) M. Hahn et al. HAEMATOLOGICA
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS)
- (2015) Arina J. ten Cate-Hoek et al. THROMBOSIS RESEARCH
- Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
- (2015) M. Hahn et al. HAEMATOLOGICA
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment
- (2014) C. Pawlyn et al. BLOOD
- A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
- (2014) E. A. Stadtmauer et al. BLOOD
- Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma
- (2014) Min Jung Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
- (2014) C. Blimark et al. HAEMATOLOGICA
- International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
- (2014) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
- (2014) Jesús F San-Miguel et al. LANCET ONCOLOGY
- Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
- (2014) Antonio Palumbo et al. LANCET ONCOLOGY
- Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
- (2014) Lotfi Benboubker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venous Thromboembolism in Multiple Myeloma
- (2014) Tommaso Za et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Chemotherapy-induced peripheral neurotoxicity: A critical analysis
- (2013) Susanna B. Park et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
- (2013) R. Chlibek et al. JOURNAL OF INFECTIOUS DISEASES
- International Myeloma Working Group recommendations for global myeloma care
- (2013) H Ludwig et al. LEUKEMIA
- A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma
- (2012) D. S. Siegel et al. BLOOD
- Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance
- (2012) S. Z. Usmani et al. BLOOD
- Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
- (2012) A. Palumbo et al. HAEMATOLOGICA
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Philip L. McCarthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
- (2011) M. Cavo et al. BLOOD
- Guidelines for supportive care in multiple myeloma 2011
- (2011) John A. Snowden et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
- (2011) S. Arastu-Kapur et al. CLINICAL CANCER RESEARCH
- Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes
- (2011) Chung-Jen Teng et al. Clinics
- Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
- (2011) David C. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
- (2011) P Kapoor et al. LEUKEMIA
- Management of treatment-emergent peripheral neuropathy in multiple myeloma
- (2011) P G Richardson et al. LEUKEMIA
- Management of treatment-related adverse events in patients with multiple myeloma
- (2010) María-Victoria Mateos CANCER TREATMENT REVIEWS
- Preventing and treating orthostatic hypotension: As easy as A, B, C
- (2010) J. J. FIGUEROA et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
- (2010) Michel Delforge et al. LANCET ONCOLOGY
- Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma
- (2010) Won-Seop Lee et al. YONSEI MEDICAL JOURNAL
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
- (2009) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection
- (2009) M. Basler et al. JOURNAL OF IMMUNOLOGY
- Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis
- (2009) Pia Raanani et al. LEUKEMIA & LYMPHOMA
- Herpes Zoster (Shingles) and Postherpetic Neuralgia
- (2009) Priya Sampathkumar et al. MAYO CLINIC PROCEEDINGS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started